Mid-gestational sevoflurane exposure inhibits fetal neural stem cell proliferation and impairs postnatal learning and memory function in a dose-dependent manner

Dev Biol. 2018 Mar 15;435(2):185-197. doi: 10.1016/j.ydbio.2018.01.022. Epub 2018 Feb 2.

Abstract

Advancements in fetal intervention procedures have led to increases in the number of pregnant women undergoing general anesthesia during the second trimester-a period characterized by extensive proliferation of fetal neural stem cells (NSCs). However, few studies have investigated the effects of mid-gestational sevoflurane exposure on fetal NSC proliferation or postnatal learning and memory function. In the present study, pregnant rats were randomly assigned to a control group (C group), a low sevoflurane concentration group (2%; L group), a high sevoflurane concentration group (3.5%; H group), a high sevoflurane concentration plus lithium chloride group (H + Li group), and a lithium chloride group (Li group) at gestational day 14. Rats received different concentrations of sevoflurane anesthesia for 2 h. The offspring rats were weaned at 28 days for behavioral testing (i.e., Morris Water Maze [MWM]), and fetal brains or postnatal hippocampal tissues were harvested for immunofluorescence staining, real-time PCR, and Western blotting analyses in order to determine the effect of sevoflurane exposure on NSC proliferation and the Wnt/β-catenin signaling pathway. Our results indicated that maternal exposure to 3.5% sevoflurane (H group) during the mid-gestational period impaired the performance of offspring rats in the MWM test, reduced NSC proliferation, and increased protein levels of fetal glycogen synthase kinase-3 beta (GSK-3β). Such treatment also decreased levels of β-catenin protein, CD44 RNA, and Cyclin D1 RNA relative to those observed in the C group. However, these effects were transiently attenuated by treatment with lithium chloride. Conversely, maternal exposure to 2% sevoflurane (L group) did not influence NSC proliferation or the Wnt signaling pathway. Our results suggest that sevoflurane exposure during the second trimester inhibits fetal NSC proliferation via the Wnt/β-catenin pathway and impairs postnatal learning and memory function in a dose-dependent manner.

Keywords: Mid-gestation; Neural stem cells; Pregnancy; Proliferation; Sevoflurane; Wnt signaling pathway.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anesthetics, Inhalation / administration & dosage
  • Anesthetics, Inhalation / toxicity*
  • Animals
  • Cell Division / drug effects
  • Cyclin D1 / biosynthesis
  • Dose-Response Relationship, Drug
  • Female
  • Fetus / drug effects*
  • Gestational Age
  • Glycogen Synthase Kinase 3 beta / antagonists & inhibitors
  • Glycogen Synthase Kinase 3 beta / metabolism
  • Hippocampus / drug effects
  • Hippocampus / embryology
  • Hippocampus / metabolism
  • Hyaluronan Receptors / biosynthesis
  • Learning Disabilities / chemically induced*
  • Lithium Chloride / therapeutic use
  • Maze Learning / drug effects
  • Memory Disorders / chemically induced*
  • Methyl Ethers / administration & dosage
  • Methyl Ethers / antagonists & inhibitors
  • Methyl Ethers / toxicity*
  • Nerve Tissue Proteins / antagonists & inhibitors
  • Nerve Tissue Proteins / metabolism
  • Neural Stem Cells / cytology
  • Neural Stem Cells / drug effects*
  • Pregnancy
  • Prenatal Exposure Delayed Effects*
  • Rats
  • Rats, Sprague-Dawley
  • Sevoflurane
  • Spatial Behavior / drug effects
  • Wnt Signaling Pathway / drug effects

Substances

  • Anesthetics, Inhalation
  • Ccnd1 protein, rat
  • Hyaluronan Receptors
  • Methyl Ethers
  • Nerve Tissue Proteins
  • Cyclin D1
  • Sevoflurane
  • Glycogen Synthase Kinase 3 beta
  • Lithium Chloride